Actress Sydney Sweeney helped bring American Eagle shares into the latest round of meme stock mania on Thursday. The ...

A timeline of key developments surrounding Sarepta Therapeutics' Duchenne muscular dystrophy drug Elevidys, and the potential ...

What Happened? Shares of game engine maker Unity (NYSE:U) fell 3.5% in the afternoon session after analysts at BTIG downgraded the stock from "Neutral" to "Sell" and set a new price target of $25.00.

Investing.com -- In a note to clients on Wednesday, BTIG downgraded Unity shares to Sell from Neutral, arguing that the stock ...

ESPO offers top-tier global exposure to video gaming and eSports, outperforming many ETFs without relying on US mega-cap tech ...

Elastic is well-positioned to benefit from AI trends, with its leadership in vector search and growing cloud revenue likely ...

Sarepta Therapeutics’ stock has dropped precipitously as questions swirl around the safety of its gene therapies. Meanwhile, the Duchenne patient community fears losing access to Elevidys while the ...

Luxury swimwear market experiences significant growth in 2025. Discover the trends, drivers of this expansion, and outlook for brands.

By understanding Peter Lynch's six stock categories, you can increase your chances of achieving long-term financial success.

Most investors don’t see the drugmaker’s executive management as credible, following the failure to disclose a patient death, ...

Sarepta stock (SRPT) declined 5% in premarket trade, after falling 36% on Friday, when it disclosed a patient death due to liver failure.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.